Genetic evolution in the metastatic progression of human pancreatic cancer studied by CGH

Gemma Armengol, Gabriel Capellà, Lourdes Farré, Miguel Angel Peinado, Rosa Miró, Maria Rosa Caballín

Producción científica: Contribución a una revistaArtículoInvestigaciónrevisión exhaustiva

12 Citas (Scopus)


Metastases are thought to be derived from emerging clones within primary tumors. Although the concept of the clonal evolution of cancer is well defined, the genetic grounds and significance of this process in human cancer progression are still poorly understood. To gain insight into the genetic basis and clonal evolution underlying the metastatic progression of human pancreatic cancer in vivo, we analyzed by comparative genomic hybridization (CGH) chromosomal imbalances in seven metastases originated in nude mice and their three corresponding orthotopically xenografted human pancreatic tumors. All metastases were found to be closely related to the corresponding orthotopic implant, adding many additional changes to the already altered copy number profile of the pancreatic tumors. Recurrent metastasis-specific alterations included gains at 16cen-q22 and 17q21-qter. CGH results from paired specimens strongly suggest that the majority of additional genetic alterations present in metastases are likely to be present in subclones in the primary tumor.
Idioma originalInglés
Páginas (desde-hasta)1703-1707
PublicaciónLaboratory Investigation
EstadoPublicada - 1 ene 2001


Profundice en los temas de investigación de 'Genetic evolution in the metastatic progression of human pancreatic cancer studied by CGH'. En conjunto forman una huella única.

Citar esto